<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32893042</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-1497</ISSN><JournalIssue CitedMedium="Internet"><Volume>97</Volume><PubDate><Year>2021</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Neurobiology of aging</Title><ISOAbbreviation>Neurobiol Aging</ISOAbbreviation></Journal><ArticleTitle>Four novel optineurin mutations in patients with sporadic amyotrophic lateral sclerosis in Mainland China.</ArticleTitle><Pagination><StartPage>149.e1</StartPage><EndPage>149.e8</EndPage><MedlinePgn>149.e1-149.e8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neurobiolaging.2020.08.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0197-4580(20)30258-X</ELocationID><Abstract><AbstractText>This study was to investigate the genetic contribution of optineurin (OPTN), a gene associated with primary open-angle glaucoma and amyotrophic lateral sclerosis (ALS), in Chinese patients with ALS. To gain additional insight into the spectrum and pathogenic relevance of this gene for ALS, we sequenced all the coding exons of OPTN and intron-exon boundaries in 398 patients with ALS [33 familial ALS (FALS), 365 unrelated sporadic ALS (SALS)] using next-generation sequencing. Six nonsynonymous variants were identified in 6 unrelated patients with SALS, in which one patient harbored 2 different OPTN variants and another carried an SETX mutation at the same time. Among those 6 variants, 4 were novel missense mutations: c.247C&gt;T (p.R83C), c.676T&gt;C (p.F226L), c.1699A&gt;G (p.Y567A), and c.1713C&gt;G (p.H571Q) (all heterozygous). The remaining 2 were already reported in previous studies. All 6 patients were spinal onset but showed differences in ALS subtypes as well as age of onset and disease progression. Taken together, we detected 4 novel missense OPTN mutations and 2 previously described mutations that might be causal for ALS, accounting for a mutant frequency of 1.10% (4/365) in patients with SALS after excluding 2 benign variants, and confirmed that OPTN mutations are common in Asian populations. In addition, our data suggested that variability in phenotype of the same mutation might partly be due to the oligogenic basis of ALS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences &amp; Peking Union Medical College (CAMS &amp; PUMC), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Yanfei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences &amp; Peking Union Medical College (CAMS &amp; PUMC), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Xinmiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences &amp; Peking Union Medical College (CAMS &amp; PUMC), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xudong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences &amp; Peking Union Medical College (CAMS &amp; PUMC), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiuli</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Beijing San Valley Medical Laboratory Co, Ltd, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Kang</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences &amp; Peking Union Medical College (CAMS &amp; PUMC), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Dongchao</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences &amp; Peking Union Medical College (CAMS &amp; PUMC), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Mingsheng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences &amp; Peking Union Medical College (CAMS &amp; PUMC), Beijing, China; Neuroscience Center, Chinese Academy of Medical Sciences &amp; Peking Union Medical College (CAMS &amp; PUMC), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guan</LastName><ForeName>Yuzhou</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences &amp; Peking Union Medical College (CAMS &amp; PUMC), Beijing, China; Neuroscience Center, Chinese Academy of Medical Sciences &amp; Peking Union Medical College (CAMS &amp; PUMC), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences &amp; Peking Union Medical College (CAMS &amp; PUMC), Beijing, China; Neuroscience Center, Chinese Academy of Medical Sciences &amp; Peking Union Medical College (CAMS &amp; PUMC), Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Liying</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences &amp; Peking Union Medical College (CAMS &amp; PUMC), Beijing, China; Neuroscience Center, Chinese Academy of Medical Sciences &amp; Peking Union Medical College (CAMS &amp; PUMC), Beijing, China. Electronic address: pumchcuily@sina.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaoguang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences &amp; Peking Union Medical College (CAMS &amp; PUMC), Beijing, China; Neuroscience Center, Chinese Academy of Medical Sciences &amp; Peking Union Medical College (CAMS &amp; PUMC), Beijing, China. Electronic address: pumchxgli@sina.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurobiol Aging</MedlineTA><NlmUniqueID>8100437</NlmUniqueID><ISSNLinking>0197-4580</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018797">Cell Cycle Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D026901">Membrane Transport Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064251">Multifunctional Enzymes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C409460">OPTN protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C484368">SETX protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.-</RegistryNumber><NameOfSubstance UI="D004265">DNA Helicases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D020365">RNA Helicases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Neurobiol Aging. 2021 Aug;104:104</RefSource><PMID Version="1">33962819</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Neurobiol Aging. 2021 Jun 18;:null</RefSource><PMID Version="1">34253421</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asian People</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018797" MajorTopicYN="N">Cell Cycle Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004265" MajorTopicYN="N">DNA Helicases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005091" MajorTopicYN="N">Exons</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="Y">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D026901" MajorTopicYN="N">Membrane Transport Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064251" MajorTopicYN="N">Multifunctional Enzymes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020365" MajorTopicYN="N">RNA Helicases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Genetics</Keyword><Keyword MajorTopicYN="N">Mainland Chinese population</Keyword><Keyword MajorTopicYN="N">Mutations</Keyword><Keyword MajorTopicYN="N">Optineurin</Keyword><Keyword MajorTopicYN="N">Phenotypes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>7</Day><Hour>5</Hour><Minute>31</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32893042</ArticleId><ArticleId IdType="doi">10.1016/j.neurobiolaging.2020.08.002</ArticleId><ArticleId IdType="pii">S0197-4580(20)30258-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>